Navigation Links
Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
Date:12/17/2008

CARLSBAD, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast:

    What:      Abbott's exercise of its option to purchase Ibis Biosciences,
               a subsidiary of Isis. Total acquisition price will be
               $215 million.

    When:      Wednesday, December 17, 2008 at 8:30 a.m. ET / 5:30 a.m. PT

    Where:    http://www.isispharm.com

    How:       Live on the Internet.  Simply log onto our Web site listed
               above.

    Contacts:  Kristina Lemonidis
               Associate Director, Corporate Development
               (760) 603-2490

               Amy Blackley, Ph.D.
               Manager, Corporate Communications
               (760) 603-2772

If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at http://www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. A
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
2. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
3. Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides
4. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
5. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
6. Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008
7. Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
8. Palatin Technologies to Report Fiscal Year 2009 First Quarter Results; Conference Call and Webcast on November 17, 2008
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
10. Cepheid to Webcast Upcoming Financial Presentations
11. PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...bleEnergyCorp.announcedtodaythatthecompanyandtheOd...arded$2millionbyWashingtonState,sCommunityEconomic...hiptoconstructthestate,sfirstspecialtybiochemicalb...twillsignificantlyspeedthedevelopmentofourbiorefin...eMarbleEnergyCEOKellyOgilvie."WearegratefultotheGo...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...Customers with Partners Validated to Process and A... , Ottawa, ON (PRWEB) Nov...r of products for biological sample collection, st...ew global partner program. The program offers sign...munity and is designed to help partners scale and ...
(Date:11/23/2009)...rigami very high-tech origami. , Researchers at ...que for fabricating three-dimensional, single-crys...ling photolithography and a self-folding process d...y a few microns thick, offer mechanical bendabilit...same material. , "This is a completely different ...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
... /PRNewswire-FirstCall/ - Angiotech Pharmaceutical...d that its corporate partner, Boston Scientific Co...comes from a substudy of patients with left main c... Express(2)(R) Paclitaxel-Eluting Coronary Stent S...k SYNTAX trial, the first randomized, controlled c...
...ay 19 In an eleventh-hour attempt to smear Ted K...has issued a press release claiming that there was...ichard Rosenbloom, a key staff member of a subsidi...oup of dissident shareholders who have offered the...lection at the annual meeting scheduled for Wednes...
...w Projects Approved in Atlanta , , ATLANTA, May ...biotechnology convention, the Kansas Bioscience Au...investments as part of a $581 million initiative t...ate. , , The funding decisions made at the Bio In...ers of innovation in biomaterials and plant biolog...
Other Biology Technology:SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 2SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 3SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 4SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 5In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 2In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 2As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 4
(Date:11/23/2009)...HAM, Ala. A new study by University of Alabama at... index (BMI) and co-existing medical conditions (c... observed among African-Americans compared to Cauc...blished online Nov. 23 in Cancer , a journal of t...tes that although BMI and co-morbidity are indepen...
(Date:11/23/2009)...like frogs and toads have existed for 360 million ...a new aquatic fungus is threatening to make many o...ember issue of Microbiology Today . , The fung...nd to be associated with waves of amphibian extinc...ia in the 1990,s. Bd infects over 350 amphibian sp...
(Date:11/23/2009)...ts have revealed how environmental irritants such ...to cough, in research published today in the Amer...cine . The authors of the study, from Imperial Col...ified the reaction inside the lungs that can trigg... irritants in the air. They suggest that their fin...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Research reveals exactly how coughing is triggered by environmental irritants 2Video 3A Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 57982 1Video 3A Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 57982 2Video 3A Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 57982 3Osseon Signs International Distribution Agreement With MBA Incorporado 57980 1Osseon Signs International Distribution Agreement With MBA Incorporado 57980 2Osseon Signs International Distribution Agreement With MBA Incorporado 57980 3GHX Joins the Oracle PartnerNetwork 57978 1GHX Joins the Oracle PartnerNetwork 57978 2GHX Joins the Oracle PartnerNetwork 57978 3
... of the biggest questions in modern oceanography i...arine biologists at the Monterey Bay Aquarium Rese...that helps answer this question, at least for anim...f Central California. After analyzing hundreds of ...leagues found that "sinkers"-the cast-off mucus ne...
...mas C. Quinn, M.D., a Johns Hopkins physician and ... 25 years leading major efforts to combat HIV and ...trategies and resources to confront the rapid "fem...sor of infectious diseases at Hopkins and a senior... and Infectious Disease, reports that women have i...
... of minuscule devices to spot cancer markers could... University researchers have found that molecular ...ody are readily detected in blood scanned by speci...cancer markers constitute only one hundred-billion...ddition to this exceptional accuracy and sensitivi...
Other Biology News:'Sinkers' provide missing piece in deep-sea puzzle 2'Sinkers' provide missing piece in deep-sea puzzle 3'Sinkers' provide missing piece in deep-sea puzzle 4AIDS expert says global strategy needed to combat feminization of HIV/AIDS 2AIDS expert says global strategy needed to combat feminization of HIV/AIDS 3Nanowires can detect molecular signs of cancer, scientists find 2Nanowires can detect molecular signs of cancer, scientists find 3
Custom siRNA, standard purity, annealed from Ambion
...es the premium quality siRNAs you need for your ge...y ordered online by providing either the 19-21 bas...ntisense siRNA sequences. (Also check out Ambion&#...ned siRNAs, which are already designed for you.) F...
Sheep Prolactin from Cell Sciences
Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: